| | | | | | | | |

Radiation Treatment After Mesothelioma Surgery: Is it Worth It?

patient_and_physicianRadiotherapy after lung-removing mesothelioma surgery is not likely to improve mesothelioma survival or quality of life.

European researchers reached that conclusion after the first Phase II randomized trial of postoperative hemithoracic (one-sided) radiotherapy in mesothelioma treatment.

Multimodal Mesothelioma Treatment

Because mesothelioma is both aggressive and highly resistant to conventional cancer therapies, most patients undergo several different types of treatment.

Radiotherapy can be used before mesothelioma surgery, after it, or instead of other treatments as a way to relieve symptoms.

In the case of the new study conducted at hospitals in Switzerland, Belgium and Germany, 113 enrolled mesothelioma patients first underwent chemotherapy to shrink their tumors, followed by extrapleural pneumonectomy (lung-removing mesothelioma surgery).

Mesothelioma patients who had good surgical results were then treated with high-dose radiotherapy to the affected side of their chest. The goal was to kill any remaining mesothelioma cells and prevent tumors from regrowing.

Radiotherapy Impact on Mesothelioma Survival

Of the 113 patients who underwent the lung-removing mesothelioma surgery, 96 achieved complete macroscopic resection or complete removal of the visible mesothelioma tumor. Fifty-four of these patients agreed to be assigned to a radiotherapy group or a non-radiotherapy control group for further treatment.

Twenty-five of the mesothelioma patients ended up receiving radiation treatment. Unfortunately, their rate of mesothelioma relapse was not significantly better than that of the non-radiotherapy group.

“Median locoregional relapse-free survival from surgery was 7.6 months in the no radiotherapy group and 9.4 months in the radiotherapy group,” reports lead researcher Rolf Stahel, MD, a molecular biologist in the University Hospital of Zurich. “Our findings do not support the routine use of hemithoracic radiotherapy for malignant pleural mesothelioma after neoadjuvant chemotherapy and extrapleural pneumonectomy.”

Complications of Radiotherapy After Mesothelioma Surgery

Not only did the post-surgical radiation treatment fail to extend mesothelioma survival, but it also caused some serious side effects in the study subjects.

Eleven percent of the patients who received radiotherapy for mesothelioma suffered from severe nausea or vomiting. Two (7%) suffered from an inflammation of the lining of the esophagus and two contracted pneumonitis, an inflammation of the walls of alveoli in the lungs.

One mesothelioma patient died from pneumonitis following the radiation treatment.

The new report is published in The Lancet, Oncology.

Source:

Stahel, RA, et al, “Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial”, October 30, 2015, The Lancet, Oncology, Epub ahead of print

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…